Skip to main content
. 2020 Jun 15;22(8):1147–1148. doi: 10.1093/europace/euaa065
Biomarkers, tissue, genetics Class References
Genetic testing should be considered in several inherited arrhythmic diseases associated with an increased risk of ventricular arrhythmia and SCD. graphic file with name euaa065ilf1.jpg 95–97
MRI with LGE to detect fibrosis and scar may be useful in assessing the risk of arrhythmic events in AF patients and patients with cardiomyopathies. graphic file with name euaa065ilf2.jpg 98–100
Plasma NT-proBNP may be useful in differentiating patients with higher vs. lower burden of AF. graphic file with name euaa065ilf2.jpg 101–105
Plasma CRP or other inflammatory markers may be useful in risk assessment, for identifying individuals with increased risk of future AF and for identifying individuals with high degree of atrial fibrosis. graphic file with name euaa065ilf2.jpg 106–108